145 related articles for article (PubMed ID: 1942310)
1. DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder.
Wood DP; Wartinger DD; Reuter V; Cordon-Cardo C; Fair WR; Chaganti RS
J Urol; 1991 Nov; 146(5):1398-401. PubMed ID: 1942310
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer.
Wood DP; Fair WR; Chaganti RS
J Urol; 1992 Jan; 147(1):274-7. PubMed ID: 1729545
[TBL] [Abstract][Full Text] [Related]
3. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Coogan CL; Estrada CR; Kapur S; Bloom KJ
Urology; 2004 Apr; 63(4):786-90. PubMed ID: 15072912
[TBL] [Abstract][Full Text] [Related]
4. No strong association between HER-2/neu protein overexpression and gene amplification in high-grade invasive urothelial carcinomas.
Caner V; Turk NS; Duzcan F; Tufan NL; Kelten EC; Zencir S; Dodurga Y; Bagci H; Duzcan SE
Pathol Oncol Res; 2008 Sep; 14(3):261-6. PubMed ID: 18415713
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
Raman JD; Mongan NP; Tickoo SK; Boorjian SA; Scherr DS; Gudas LJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8570-6. PubMed ID: 16361539
[TBL] [Abstract][Full Text] [Related]
6. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder.
Jalali Nadoushan MR; Taheri T; Jouian N; Zaeri F
Urol J; 2007; 4(3):151-4. PubMed ID: 17987577
[TBL] [Abstract][Full Text] [Related]
8. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.
Huang WC; Taylor S; Nguyen TB; Tomaszewski JE; Libertino JA; Malkowicz SB; McGarvey TW
DNA Cell Biol; 2002 Oct; 21(10):707-15. PubMed ID: 12443540
[TBL] [Abstract][Full Text] [Related]
9. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.
Zhau HE; Zhang X; von Eschenbach AC; Scorsone K; Babaian RJ; Ro JY; Hung MC
Mol Carcinog; 1990; 3(5):254-7. PubMed ID: 1978777
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma.
Beckhardt RN; Kiyokawa N; Xi L; Liu TJ; Hung MC; el-Naggar AK; Zhang HZ; Clayman GL
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1265-70. PubMed ID: 7576473
[TBL] [Abstract][Full Text] [Related]
11. Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Montie JE
J Urol; 2005 Jun; 173(6):1921-2. PubMed ID: 15879779
[No Abstract] [Full Text] [Related]
12. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
[TBL] [Abstract][Full Text] [Related]
13. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
14. Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization.
Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Hirano M; Hayashida K; Mizumukai E; Nanaura H; Honda N
Oncol Rep; 2007 Nov; 18(5):1183-7. PubMed ID: 17914570
[TBL] [Abstract][Full Text] [Related]
15. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.
Hung MC; Zhang X; Yan DH; Zhang HZ; He GP; Zhang TQ; Shi DR
Cancer Lett; 1992 Jan; 61(2):95-103. PubMed ID: 1346099
[TBL] [Abstract][Full Text] [Related]
17. Expression of HER-2/neu in renal-cell carcinoma. Correlation with histologic subtypes and differentiation.
Rotter M; Block T; Busch R; Thanner S; Höfler H
Int J Cancer; 1992 Sep; 52(2):213-7. PubMed ID: 1355755
[TBL] [Abstract][Full Text] [Related]
18. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
19. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
[TBL] [Abstract][Full Text] [Related]
20. Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.
Tsuda H; Akiyama F; Terasaki H; Hasegawa T; Kurosumi M; Shimadzu M; Yamamori S; Sakamoto G
Cancer; 2001 Dec; 92(12):2965-74. PubMed ID: 11753973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
